Bank of New York Mellon’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
TCBWMS
QC
MFS
JIR
SOW
PFSRSONJ
Bank of New York Mellon's IRD Position: Q2 2026 in Review
Bank of New York Mellon opened a new position in Opus Genetics (IRD) in Q2 2026: 122,479 shares worth $503K. The stake represents ﹤0.01% of the portfolio and ranks #3752 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in IRD as recently as Q1 2023.
Bank of New York Mellon first reported a position in IRD in Q2 2013 and has held it in 24 quarters since. 27 funds tracked by Wall St. Rank hold IRD as of Q2 2026.
- Bank of New York Mellon held 122,479 shares of Opus Genetics worth $503K as of Q2 2026.
- Opus Genetics was a new Bank of New York Mellon position in Q2 2026.
- Opus Genetics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3752 holding.
- Bank of New York Mellon first reported a position in Opus Genetics in Q2 2013 and has held it in 24 quarters since.
- 27 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.